New User? Sign Up | Sign In

Insider Trading - Prevail Therapeutics Inc. (PRVL)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
PRVL Insider Trading Transactions for Prevail Therapeutics Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-06-24
Purchase
2019-06-26
4:54 pm
Prevail Therapeutics Inc. PRVL ORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
Director
10% Owner
882,352 $17 $14,999,984 13,822,463
(Indirect)
View
2019-06-24
Purchase
2019-06-26
4:55 pm
Prevail Therapeutics Inc. PRVL GORDON CARL L
Director
10% Owner
882,352 $17 $14,999,984 13,822,463
(Indirect)
View
2019-06-24
Purchase
2019-06-26
4:56 pm
Prevail Therapeutics Inc. PRVL Thompson Peter A.
Director
10% Owner
882,352 $17 $14,999,984 13,822,463
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-06-24
Conversion
2019-06-25
6:51 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL Nader Francois
Director
23,747 $0 0
(Indirect)
View
2019-06-24
Conversion
2019-06-25
6:51 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL Nader Francois
Director
23,747 $0 0
(Indirect)
View
2019-06-24
Conversion
2019-06-26
4:54 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL ORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
Director
10% Owner
10,510,111 $0 13,822,463
(Indirect)
View
2019-06-24
Conversion
2019-06-26
4:54 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL ORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
Director
10% Owner
6,399,000 $0 13,822,463
(Indirect)
View
2019-06-24
Conversion
2019-06-26
4:54 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL ORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
Director
10% Owner
3,099,612 $0 13,822,463
(Indirect)
View
2019-06-24
Conversion
2019-06-26
4:54 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL ORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
Director
10% Owner
1,011,499 $0 13,822,463
(Indirect)
View
2019-06-24
Conversion
2019-06-26
4:55 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL GORDON CARL L
Director
10% Owner
10,510,111 $0 13,822,463
(Indirect)
View
2019-06-24
Conversion
2019-06-26
4:55 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL GORDON CARL L
Director
10% Owner
6,399,000 $0 13,822,463
(Indirect)
View
2019-06-24
Conversion
2019-06-26
4:55 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL GORDON CARL L
Director
10% Owner
3,099,612 $0 13,822,463
(Indirect)
View
2019-06-24
Conversion
2019-06-26
4:55 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL GORDON CARL L
Director
10% Owner
1,011,499 $0 13,822,463
(Indirect)
View
2019-06-24
Conversion
2019-06-26
4:56 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL Thompson Peter A.
Director
10% Owner
10,510,111 $0 13,822,463
(Indirect)
View
2019-06-24
Conversion
2019-06-26
4:56 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL Thompson Peter A.
Director
10% Owner
6,399,000 $0 13,822,463
(Indirect)
View
2019-06-24
Conversion
2019-06-26
4:56 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL Thompson Peter A.
Director
10% Owner
3,099,612 $0 13,822,463
(Indirect)
View
2019-06-24
Conversion
2019-06-26
4:56 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL Thompson Peter A.
Director
10% Owner
1,011,499 $0 13,822,463
(Indirect)
View
2019-11-15
Option Award
2019-11-18
5:35 pm
N/A
2029-11-15
Prevail Therapeutics Inc. PRVL Sheng Morgan
Director
20,000 $10.62 20,000
(Direct)
View
2019-12-24
Exercise
2020-03-11
4:47 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL Minkow Emily
Chief Business Officer
13,000 $0.18 149,000
(Direct)
View
2019-12-24
Exercise
2020-03-11
4:47 pm
N/A
2027-10-24
Prevail Therapeutics Inc. PRVL Minkow Emily
Chief Business Officer
13,000 $0.18 149,000
(Direct)
View
2020-02-19
Option Award
2020-03-11
4:49 pm
N/A
2030-02-19
Prevail Therapeutics Inc. PRVL Sevigny Jeffrey
Chief Medical Officer
89,000 $16.91 89,000
(Direct)
View
2020-02-19
Option Award
2020-03-11
4:50 pm
N/A
2030-02-19
Prevail Therapeutics Inc. PRVL Abeliovich Asa
CEO
10% Owner
250,000 $16.91 250,000
(Direct)
View
2020-02-19
Option Award
2020-03-11
4:51 pm
N/A
2030-02-19
Prevail Therapeutics Inc. PRVL Kaplan Brett
CFO
95,000 $16.91 95,000
(Direct)
View
2020-02-19
Option Award
2020-03-11
4:52 pm
N/A
2030-02-19
Prevail Therapeutics Inc. PRVL Minkow Emily
Chief Business Officer
54,000 $16.91 54,000
(Direct)
View
2020-02-19
Option Award
2020-03-11
4:53 pm
N/A
2030-02-19
Prevail Therapeutics Inc. PRVL Hefti Franz
Chief Development Officer
62,200 $16.91 62,200
(Direct)
View
2020-02-19
Option Award
2020-03-11
4:54 pm
N/A
2030-02-19
Prevail Therapeutics Inc. PRVL Dai Yong
CTO
43,500 $16.91 43,500
(Direct)
View
2020-06-02
Option Award
2020-06-03
6:43 pm
N/A
2030-06-02
Prevail Therapeutics Inc. PRVL Schwartz Kira M.
General Counsel
100,000 $16.68 100,000
(Direct)
View
2020-06-17
Option Award
2020-06-19
6:36 pm
N/A
2030-06-17
Prevail Therapeutics Inc. PRVL Nader Francois
Director
17,000 $16.98 17,000
(Direct)
View
2020-06-17
Option Award
2020-06-19
6:37 pm
N/A
2030-06-17
Prevail Therapeutics Inc. PRVL Adams Timothy M
Director
17,000 $16.98 17,000
(Direct)
View
2020-06-17
Option Award
2020-06-19
6:37 pm
N/A
2030-06-17
Prevail Therapeutics Inc. PRVL GORDON CARL L
Director
10% Owner
17,000 $16.98 17,000
(Direct)
View
2020-06-17
Option Award
2020-06-19
6:38 pm
N/A
2030-06-17
Prevail Therapeutics Inc. PRVL Nussbaum Ran
Director
17,000 $16.98 17,000
(Direct)
View
2020-06-17
Option Award
2020-06-19
6:39 pm
N/A
2030-06-17
Prevail Therapeutics Inc. PRVL Sheng Morgan
Director
17,000 $16.98 17,000
(Direct)
View
2020-06-17
Option Award
2020-06-19
6:40 pm
N/A
2030-06-17
Prevail Therapeutics Inc. PRVL Thompson Peter A.
Director
10% Owner
17,000 $16.98 17,000
(Direct)
View
2020-09-09
Option Award
2020-09-11
08:30 am
N/A
2030-09-09
Prevail Therapeutics Inc. PRVL Carson William H.
Director
34,000 $11.11 34,000
(Direct)
View